Oncospace Inc. announces channel partner agreement with schneider & schulte
BALTIMORE, JULY 11, 2023—Oncospace, Inc. today announced the following:
Channel Partnership Agreement with schneider & schulte
Oncospace has entered into a channel partnership agreement with schneider & schulte for the sale and distribution of the Oncospace Patient Data Conversion service in Germany, Austria, Switzerland, and the BeNeLux countries.
schneider & schulte has extensive experience in commercializing selling and marketing radiation oncology and medical imaging technologies to early adopter healthcare practices in strategically important markets around the world. Oncospace is proud to have a like-minded trailblazer as a partner.
All product and company names are trademarks ™ or registered ® trademarks of their respective holders. Use of these marks does not imply any affiliation with or endorsement by their respective holders.
ABOUT Oncospace, Inc.: Oncospace attracts and best serves, lean, high-throughput radiation oncology clinics that share a vision of disrupting current radiotherapy planning conventions. Together, we collaborate on AI-powered, data-driven, automation strategies that optimize outcomes for the patient and the practice. Our cloud-native, data analytics platform is built with industry leading security and healthcare connectivity that leverages a customer’s existing investments in clinical software applications. For more information, visit www.oncospace.com and follow us on LinkedIn:
(https://www.linkedin.com/company/oncospace-inc/about/).
Contact:
Todd Deterding; Oncospace, Inc.
(443) 773-2271
